Janssen collaborates on gene therapies for retinal disorders 05-Feb-2019 By Maggie Lynch Janssen enters collaboration with MeiraGTx for the development and commercialization of retinal disorder gene therapies.
MilliporeSigma and genOway enter CRISPR collaboration 19-Dec-2018 By Maggie Lynch genOway has acquired exclusive rights to MilliporeSigma's genome-editing patents to produce and sell new rodent models.
Gene editing partnership to provide custom cells for drug discovery 06-Nov-2018 By Maggie Lynch Ncardia and Horizon Discovery have partnered to provide custom, genetically-modified and differentiated human cells for drug discovery and preclinical models.
